BiotechTube
Home/EvlaBio/Christian Stegmann
CS

Christian Stegmann

CSO

EvlaBio

Therapeutic Areas

Cardiorenal DiseaseChronic Kidney DiseaseCardiovascular Disease

EvlaBio Pipeline

DrugIndicationPhase
Anti-FGFR4 mAbLeft Ventricular Hypertrophy in Chronic Kidney DiseasePre-clinical

Leadership Team at EvlaBio

WV
Wenzel von der Heydte
CEO & Co-founder
TK
Thomas Kirmeier
COO & Co-founder
View full EvlaBio profile